Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Observational × RAS Wild Type mCRC × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Breast Neoplasms 460 Neoplasms 314 Carcinoma, Non-Small-Cell Lung 266 Prostatic Neoplasms 213 Colorectal Neoplasms 207 Lung Neoplasms 173 Multiple Myeloma 122 Melanoma 110 Carcinoma, Renal Cell 107 Ovarian Neoplasms 93 Carcinoma, Hepatocellular 77 Pancreatic Neoplasms 69 Urinary Bladder Neoplasms 65 Neoplasm Metastasis 64 Stomach Neoplasms 63 Leukemia, Lymphocytic, Chronic, B-Cell 61 Colonic Neoplasms 59 Leukemia, Myeloid, Acute 52 Uterine Cervical Neoplasms 50 Recurrence 48 Liver Neoplasms 46 Lymphoma, Follicular 45 Lymphoma 44 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 38 Esophageal Neoplasms 37 Precursor Cell Lymphoblastic Leukemia-Lymphoma 36 Lymphoma, Large B-Cell, Diffuse 35 Hematologic Neoplasms 35 Lymphoma, Non-Hodgkin 34 Kidney Neoplasms 34

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02792478 2024-05-13

PERSEIDA

Amgen

RAS Wild Type mCRC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡